Jedan od glavnih ciljeva Life4me+ — jeste da spreči nove slučajeve HIV-a i ostalih polno prenosivih infekcija, hepatitisa C i tuberkuloze.

Aplikacija pomaže da se uspostavi anonimna komunikacija između lekara i osoba koje žive sa HIV-om. Omogućava da lakše organizujete Vaš raspored upotrebe lekova i da postavite prikrivene i personalizovane podsetnike.

Sve vesti

Arhiviraj

✕

13 децембар 2017

5183

New tuberculosis drugs possible with understanding of old antibiotic

New tuberculosis drugs possible with understanding of old antibiotic

Only by truly understanding molecular and cellular events caused by antibiotics or in response to their presence will we truly understand how to make improved drugs, which are much needed in face of the current threat of antibiotic resistance.

13 децембар 2017

5599

The New Plan to ‘Make HIV History’ in Australia

The New Plan to ‘Make HIV History’ in Australia

The new plan would give wider access to a highly effective preventative drug named PrEP and deliver it to at-risk communities around Australia. It would also save $2 billion in future public health costs.

12 децембар 2017

5292

BRICS Countries Are Making Progress Towards Universal Health Coverage

BRICS Countries Are Making Progress Towards Universal Health Coverage

The emerging economies of Brazil, Russia, India, China and South Africa — representing almost half the world’s population — are all taking steps toward Universal Health Coverage.

12 децембар 2017

5364

Kazatchkine appointed UNAIDS Special Adviser

Kazatchkine appointed UNAIDS Special Adviser

Michel Kazatchkine appointed UNAIDS Special Adviser on HIV, Tuberculosis and Hepatitis C in Eastern Europe and Central Asia.

11 децембар 2017

5068

New hepatitis C therapy approved in UK

New hepatitis C therapy approved in UK

Maviret (Glecaprevir-pibrentasvir) has been recommended for adults with chronic hepatitis C. The treatment is an additional option suitable for all genotypes, with or without scarring of the liver, and in people who are untreated or have been treated before with interferon-based ...

11 децембар 2017

5051

Grantmaking for HIV Totaled a Record $680 Million

Grantmaking for HIV Totaled a Record $680 Million

Global philanthropic support for HIV/AIDS initiatives totaled a record $680 million in 2016. The top twenty funders accounted for 87 percent of 2016 resources. The top recipient of country-level philanthropic funding for HIV/AIDS initiatives was the U.S.

11 децембар 2017

4774

UNAIDS and IOM signed a partnership agreement

UNAIDS and IOM signed a partnership agreement

UNAIDS and the International Organization for Migration signed a new cooperation agreement to promote access to HIV prevention, treatment, care and support services for migrants, mobile populations and people affected by humanitarian emergencies.

8 децембар 2017

5366

NIH launches HIV prevention trial of long-acting injectable cabotegravir compared with daily oral PrEP

NIH launches HIV prevention trial of long-acting injectable cabotegravir compared with daily oral PrEP

The first large-scale clinical trial of a long-acting injectable medication for HIV prevention in sexually active women has begun. The study will examine whether a long-acting form of the investigational anti-HIV drug cabotegravir injected once every eight weeks can safely ...

8 децембар 2017

5332

Tilda Swinton supports the groundbreaking French HIV treatment

Tilda Swinton supports the groundbreaking French HIV treatment

ICCARRE is a groundbreaking programme reducing the amount of medication required by HIV/AIDS patients during treatment. It presents a short film directed by Blanca Li and starring Tilda Swinton.

7 децембар 2017

4879

Higher risk sexual behaviour is associated with unawareness of HIV-positivity

Higher risk sexual behaviour is associated with unawareness of HIV-positivity

People with HIV who don't use condoms consistently are more likely to be unaware they are HIV-positive or to have a detectable viral load when their HIV infection has been diagnosed.

1...31 32 33 34 35...97